Griffin Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,809
Closed -$1.88M 243
2021
Q3
$1.88M Sell
14,809
-3,555
-19% -$518K 0.24% 106
2021
Q2
$3.05M Sell
18,364
-1,465
-7% -$237K 0.37% 73
2021
Q1
$3.6M Buy
19,829
+3,412
+21% +$791K 0.46% 58
2020
Q4
$3.28M Buy
16,417
+12,643
+335% +$2.57M 0.44% 57
2020
Q3
$827K Buy
3,774
+52
+1% +$11K 0.13% 125
2020
Q2
$710K Buy
3,722
+686
+23% +$120K 0.11% 130
2020
Q1
$471K Buy
+3,036
New +$353K 0.09% 141
2019
Q3
Sell
-2,000
Closed -$133K 452
2019
Q2
$133K Buy
+2,000
New +$117K 0.02% 274

Other funds holding TDOC

Griffin Asset Management's TDOC Position: Q4 2021 in Review

Griffin Asset Management sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 14,809 shares — an estimated $1.88M sold.

Griffin Asset Management first reported a position in TDOC in Q2 2019 and held it in 8 quarters. The position peaked at $3.6M in Q1 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Griffin Asset Management reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Griffin Asset Management sold 14,809 Teladoc Health shares in Q4 2021, an estimated $1.88M.
  • Griffin Asset Management first reported a position in Teladoc Health in Q2 2019 and held it in 8 quarters.
  • Griffin Asset Management's Teladoc Health position peaked at $3.6M in Q1 2021.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Griffin Asset Management's 13F filing for Q4 2021, filed 28 Jan 2022.